Literature DB >> 1365656

Effects of physostigmine on stimulus encoding in a memory-scanning task.

A Wetherell1.   

Abstract

Previous studies of the effects of physostigmine on memory have involved other drugs, a memory that has already been impaired, or both, often with contradictory results. Also, traditional memory tests do not differentiate memory from other task components such as perception and response, and drug effects on these could be mistaken for effects on memory. The present study was designed to investigate the effects of physostigmine alone on normal memory using Sternberg's additive-factor, memory-scanning task, with additional variables to isolate effects on stimulus encoding and response stages. Sixteen volunteers participated, the design was between-groups, and physostigmine or normal saline was given, double-blind, by intravenous infusion for 70 min. The drug had no effect on the memory component of the task, but significantly improved stimulus encoding (P < 0.001). Thus, it is possible that physostigmine improves performance on memory tests by improving perception as well as, or instead of, memory.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1365656     DOI: 10.1007/bf02245500

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  32 in total

1.  Long-term administration of oral physostigmine and lecithin improve memory in Alzheimer's disease.

Authors:  H S Levin; B H Peters
Journal:  Ann Neurol       Date:  1984-02       Impact factor: 10.422

2.  Secobarbital and information processing.

Authors:  O H Rundell; H L Williams; B K Lester
Journal:  Percept Mot Skills       Date:  1978-06

3.  Sensitivity of some human cognitive functions to effects of methamphetamine and secobarbital.

Authors:  R C Mohs; J R Tinklenberg; W T Roth; B S Kopell
Journal:  Drug Alcohol Depend       Date:  1980-02       Impact factor: 4.492

4.  The use of Sternberg's memory-scanning paradigm in assessing effects of chemical exposure.

Authors:  P J Smith; G D Langolf
Journal:  Hum Factors       Date:  1981-12       Impact factor: 2.888

5.  Physostigmine and its effect on six patients with dementia.

Authors:  J W Ashford; S Soldinger; J Schaeffer; L Cochran; L F Jarvik
Journal:  Am J Psychiatry       Date:  1981-06       Impact factor: 18.112

6.  Physostigmine: effects on cognition and affect in normal subjects.

Authors:  K L Davis; L E Hollister; J Overall; A Johnson; K Train
Journal:  Psychopharmacology (Berl)       Date:  1976-12-21       Impact factor: 4.530

7.  Effect of physostigmine and scopolamine on the memory functions of chess players.

Authors:  R Liljequist; M J Mattila
Journal:  Med Biol       Date:  1979

8.  The effect of methylphenidate on information processing.

Authors:  H Naylor; R Halliday; E Callaway
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine.

Authors:  K L Davis; R C Mohs
Journal:  Am J Psychiatry       Date:  1982-11       Impact factor: 18.112

10.  Memory enhancement after physostigmine treatment in the amnesic syndrome.

Authors:  B H Peters; H S Levin
Journal:  Arch Neurol       Date:  1977-04
View more
  3 in total

1.  Assessment of a combination of physostigmine and scopolamine as pretreatment against the behavioural effects of organophosphates in the common marmoset (Callithrix jacchus).

Authors:  N G Muggleton; A P Bowditch; H S Crofts; E A M Scott; P C Pearce
Journal:  Psychopharmacology (Berl)       Date:  2003-02-13       Impact factor: 4.530

Review 2.  Performance tests.

Authors:  A Wetherell
Journal:  Environ Health Perspect       Date:  1996-04       Impact factor: 9.031

Review 3.  Cognitive and psychomotor performance tests and experiment design in multiple chemical sensitivity.

Authors:  A Wetherell
Journal:  Environ Health Perspect       Date:  1997-03       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.